203 related articles for article (PubMed ID: 27430936)
1. Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4.
Li Y; Jiang D; Zhang Q; Liu X; Cai Z
Int J Mol Med; 2016 Sep; 38(3):803-11. PubMed ID: 27430936
[TBL] [Abstract][Full Text] [Related]
2. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.
Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG
Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342
[TBL] [Abstract][Full Text] [Related]
3. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma.
Liang H; Wang F; Chu D; Zhang W; Liao Z; Fu Z; Yan X; Zhu H; Guo W; Zhang Y; Guan W; Chen X
Sci Rep; 2016 Mar; 6():23772. PubMed ID: 27021515
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
[TBL] [Abstract][Full Text] [Related]
6. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-β1/Smad2/MMP-9 signal.
Cao WH; Liu XP; Meng SL; Gao YW; Wang Y; Ma ZL; Wang XG; Wang HB
Eur Rev Med Pharmacol Sci; 2016; 20(6):1115-22. PubMed ID: 27049265
[TBL] [Abstract][Full Text] [Related]
7. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma.
Hou X; Wang L; Zhang L; Pan X; Zhao W
FEBS Lett; 2013 Feb; 587(4):311-6. PubMed ID: 23313255
[TBL] [Abstract][Full Text] [Related]
10. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.
Nieves-Alicea R; Colburn NH; Simeone AM; Tari AM
Breast Cancer Res Treat; 2009 Mar; 114(2):203-9. PubMed ID: 18386173
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer.
Yun SI; Kim HH; Yoon JH; Park WS; Hahn MJ; Kim HC; Chung CH; Kim KK
Mol Oncol; 2015 Nov; 9(9):1834-51. PubMed ID: 26189775
[TBL] [Abstract][Full Text] [Related]
15. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.
Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R
Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163
[TBL] [Abstract][Full Text] [Related]
16. A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.
Geng N; Li Y; Zhang W; Wang F; Wang X; Jin Z; Xing Y; Li D; Zhang H; Li Y; Li X; Cheng M; Jin F; Li F
Int J Cancer; 2020 Feb; 146(4):1139-1151. PubMed ID: 31219614
[TBL] [Abstract][Full Text] [Related]
17. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.
Zhu L; Yang S; He S; Qiang F; Cai J; Liu R; Gu C; Guo Z; Wang C; Zhang W; Zhang C; Wang Y
J Mol Histol; 2016 Feb; 47(1):69-80. PubMed ID: 26712154
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
[TBL] [Abstract][Full Text] [Related]
20. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
